deltatrials
Completed PHASE4 INTERVENTIONAL 2-arm NCT00159133

Prodrome-Based Early Intervention With Antipsychotics vs. Benzodiazepines in First-Episode Schizophrenia

Prodrome-Based Early Intervention With Antipsychotics vs. Benzodiazepine in Patients With First-Episode Schizophrenia After One Year Maintenance Treatment Under Further Maintenance Treatment vs. Stepwise Discontinued Drugs

Sponsor: German Federal Ministry of Education and Research

Updated 5 times since 2017 Last updated: Jan 28, 2008 Started: Nov 30, 2001 Primary completion: Jun 30, 2006 Completion: Jun 30, 2006
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Psychoses and Schizophrenia, this trial is completed. The trial is conducted by German Federal Ministry of Education and Research and has accumulated 5 data snapshots since 2001. Psychiatric clinical trials are essential for establishing evidence-based treatment standards.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 23 months · monthly snapshotCompleted

Change History

5 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE4

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE4

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE4

    First recorded

Nov 2001

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • German Federal Ministry of Education and Research
  • German Research Network On Schizophrenia
  • Heinrich-Heine University, Duesseldorf
  • Humboldt-Universität zu Berlin
  • Janssen-Cilag Ltd.
  • Ludwig-Maximilians - University of Munich
  • Mainz University
  • Martin-Luther-Universität Halle-Wittenberg
  • RWTH Aachen University
  • University Hospital Tuebingen
  • University of Bonn
  • University of Cologne
  • University of Göttingen
  • University of Jena
  • University of Mannheim
  • University of Wuerzburg
  • Universität Duisburg-Essen
Data source: Heinrich-Heine University, Duesseldorf

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations